MRI after treatment of locally advanced rectal cancer: how to report tumor response—the MERCURY experience

UB Patel, LK Blomqvist, F Taylor… - American Journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The Magnetic Resonance Imaging and Rectal Cancer European Equivalence
(MERCURY) Study validated the use of MRI for posttreatment staging and its correlation with …

MRI for rectal cancer: staging, mrCRM, EMVI, lymph node staging and post-treatment response

DDB Bates, M El Homsi, KJ Chang, N Lalwani… - Clinical colorectal …, 2022 - Elsevier
Rectal cancer is a relatively common malignancy in the United States. Magnetic resonance
imaging (MRI) of rectal cancer has evolved tremendously in recent years, and has become a …

Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort …

AG Renehan, L Malcomson, R Emsley… - The Lancet …, 2016 - thelancet.com
Background Induction of a clinical complete response with chemoradiotherapy, followed by
observation via a watch-and-wait approach, has emerged as a management option for …

MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy

N Horvat, H Veeraraghavan, M Khan, I Blazic, J Zheng… - Radiology, 2018 - pubs.rsna.org
Purpose To investigate the value of T2-weighted–based radiomics compared with
qualitative assessment at T2-weighted imaging and diffusion-weighted (DW) imaging for …

[HTML][HTML] EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum

CJH van de Velde, PG Boelens, JM Borras… - European journal of …, 2014 - Elsevier
Background Care for patients with colon and rectal cancer has improved in the last 20 years;
however considerable variation still exists in cancer management and outcome between …

Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer

F Sclafani, G Brown, D Cunningham… - British journal of …, 2017 - nature.com
Background: Limited data exist regarding the correlation between MRI tumour regression
grade (mrTRG) and pathological TRG (pTRG) in rectal cancer. Methods: mrTRG and pTRG …

Achieving a complete clinical response after neoadjuvant chemoradiation that does not require surgical resection: it may take longer than you think!

A Habr-Gama, GP São Julião… - Diseases of the Colon …, 2019 - journals.lww.com
BACKGROUND: Patients with rectal cancer who achieve complete clinical response after
neoadjuvant chemoradiation have been managed by organ-preserving strategies and …

Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference

M Morino, M Risio, S Bach, R Beets-Tan, K Bujko… - Surgical …, 2015 - Springer
Background The last 30 years have witnessed a significant increase in the diagnosis of early-
stage rectal cancer and the development of new strategies to reduce the treatment-related …

Neoadjuvant rectal (NAR) score: a new surrogate endpoint in rectal cancer clinical trials

TJ George, CJ Allegra, G Yothers - Current colorectal cancer reports, 2015 - Springer
The conduct of clinical trials in colorectal cancer has historically relied upon endpoints such
as disease-free (DFS) or overall survival (OS). While ideal, these endpoints require long …

Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation

A Habr-Gama, PB Lynn, JMN Jorge… - Diseases of the Colon …, 2016 - journals.lww.com
BACKGROUND: Organ-preserving strategies have been considered for patients with distal
rectal cancer and complete or near-complete response to neoadjuvant chemoradiation to …